Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 186

1.

Time Course and Predictors of Suicidal Ideation During Citalopram Treatment in the STAR*D Trial.

Coughlin CG, Jakubovski E, Bloch MH.

J Clin Psychiatry. 2016 Oct;77(10):e1262-e1269. doi: 10.4088/JCP.15m10075.

PMID:
27631142
2.

Pharmacological treatment of children and adolescents with depression.

Vitiello B, Ordóñez AE.

Expert Opin Pharmacother. 2016 Dec;17(17):2273-2279. Epub 2016 Oct 14. Review.

PMID:
27690663
3.

Which SSRIs most effectively treat depression in adolescents?

DeLucia V, Kelsberg G, Safranek S.

J Fam Pract. 2016 Sep;65(9):632-4.

PMID:
27672691
4.

Neuropsychiatric Presentation of Wilson Disease in an Adolescent Male.

Schindler EA, Guo XM, Schrag M, Ghoshal S, Schilsky ML, Beslow LA.

Neuropediatrics. 2016 Oct;47(5):346-7. doi: 10.1055/s-0036-1586225. Epub 2016 Aug 4. No abstract available.

PMID:
27490186
5.
6.

Randomized controlled trials of serotonin-norepinephrine reuptake inhibitor in treating major depressive disorder in children and adolescents: a meta-analysis of efficacy and acceptability.

Xu Y, Bai SJ, Lan XH, Qin B, Huang T, Xie P.

Braz J Med Biol Res. 2016 May 24;49(6). pii: S0100-879X2016000600704. doi: 10.1590/1414-431X20164806. Review.

7.

Comparing the Effects of Sertraline with Duloxetine for Depression Severity and Symptoms: A Double-Blind, Randomized Controlled Trial.

Mowla A, Dastgheib SA, Razeghian Jahromi L.

Clin Drug Investig. 2016 Jul;36(7):539-43. doi: 10.1007/s40261-016-0399-6.

PMID:
27071759
8.

[Psychopharmaceuticals for treatment of suicidal patients and for suicide prevention].

Haußmann R, Bauer M, Lewitzka U, Müller-Oerlinghausen B.

Nervenarzt. 2016 May;87(5):483-7. doi: 10.1007/s00115-016-0088-y. Review. German.

PMID:
26952239
9.

Suicidality and aggression during antidepressant treatment: systematic review and meta-analyses based on clinical study reports.

Sharma T, Guski LS, Freund N, Gøtzsche PC.

BMJ. 2016 Jan 27;352:i65. doi: 10.1136/bmj.i65. Review.

10.

The association between suicidality and treatment with selective serotonin reuptake inhibitors in older people with major depression: a systematic review.

KoKoAung E, Cavenett S, McArthur A, Aromataris E.

JBI Database System Rev Implement Rep. 2015 Apr 17;13(3):174-205. doi: 10.11124/jbisrir-2015-2272. Review.

PMID:
26447056
11.

Suicidal risk from TADS study was higher than it first appeared.

Högberg G, Antonuccio DO, Healy D.

Int J Risk Saf Med. 2015;27(2):85-91. doi: 10.3233/JRS-150645.

PMID:
26410011
12.

Acute and longer-term safety results from a pooled analysis of duloxetine studies for the treatment of children and adolescents with major depressive disorder.

Emslie GJ, Wells TG, Prakash A, Zhang Q, Pangallo BA, Bangs ME, March JS.

J Child Adolesc Psychopharmacol. 2015 May;25(4):293-305. doi: 10.1089/cap.2014.0076.

PMID:
25978741
13.

The role of 5-HT1A receptors in mediating acute negative effects of antidepressants: implications in pediatric depression.

Rahn KA, Cao YJ, Hendrix CW, Kaplin AI.

Transl Psychiatry. 2015 May 5;5:e563. doi: 10.1038/tp.2015.57.

14.

Vitamin C as an adjuvant for treating major depressive disorder and suicidal behavior, a randomized placebo-controlled clinical trial.

Sahraian A, Ghanizadeh A, Kazemeini F.

Trials. 2015 Mar 14;16:94. doi: 10.1186/s13063-015-0609-1.

15.

A randomized, placebo-controlled study of duloxetine for the treatment of children and adolescents with generalized anxiety disorder.

Strawn JR, Prakash A, Zhang Q, Pangallo BA, Stroud CE, Cai N, Findling RL.

J Am Acad Child Adolesc Psychiatry. 2015 Apr;54(4):283-93. doi: 10.1016/j.jaac.2015.01.008. Epub 2015 Jan 29.

PMID:
25791145
16.

A randomized, double-blind, duloxetine-referenced study comparing efficacy and tolerability of 2 fixed doses of vortioxetine in the acute treatment of adults with MDD.

Mahableshwarkar AR, Jacobsen PL, Chen Y, Serenko M, Trivedi MH.

Psychopharmacology (Berl). 2015 Jun;232(12):2061-70. doi: 10.1007/s00213-014-3839-0. Epub 2015 Jan 11.

17.

Treatment-related improvement in neuropsychological functioning in suicidal depressed patients: paroxetine vs. bupropion.

Gorlyn M, Keilp J, Burke A, Oquendo M, Mann JJ, Grunebaum M.

Psychiatry Res. 2015 Feb 28;225(3):407-12. doi: 10.1016/j.psychres.2014.12.004. Epub 2014 Dec 13.

18.

A naturalistic study of suicidal adolescents treated with an SSRI: suicidal ideation and behavior during 3-month post-hospitalization period.

Ghaziuddin N, Merchant C, Dopp R, King C.

Asian J Psychiatr. 2014 Oct;11:13-9. doi: 10.1016/j.ajp.2014.03.014. Epub 2014 Apr 8.

19.

Efficacy and tolerability of antidepressants in pediatric anxiety disorders: a systematic review and meta-analysis.

Strawn JR, Welge JA, Wehry AM, Keeshin B, Rynn MA.

Depress Anxiety. 2015 Mar;32(3):149-57. doi: 10.1002/da.22329. Epub 2014 Nov 28. Review.

20.

Supplemental Content

Loading ...
Support Center